Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
|
July 16, 2026
Baseline inflammatory markers, CPAP adherence, impacts on cardiovascular events, and mortality in obstructive sleep apnea: retrospective naturalistic study
Petr Mooz, Samuel Genzor, Jan Mizera, et al.
Viruses
|
November 11, 2022
Network Analysis for Uncovering the Relationship between Host Response and Clinical Factors to Virus Pathogen: Lessons from SARS-CoV-2
Milan Sova, Milos Kudelka, Milan Raska, et al.
British Journal of Anaesthesia
|
May 15, 2025
Multimodal prehabilitation before lung resection surgery: a multicentre randomised controlled trial
Kristian Brat, Milan Sova, Pavel Homolka, et al.
Cell Reports
|
June 20, 2025
The SARS-CoV-2 trigger highlights host interleukin 1 genetics in Epstein-Barr virus reactivation
Petra Schneiderova, Jan Mizera, Arootin Gharibian, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
February 16, 2025
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study
Bernardo Sousa-Pinto, Elísio M Costa, Rafael José Vieira, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 25, 2022
Cutoff Values of MASK-air Patient-Reported Outcome Measures
Bernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Allergy
|
March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world data
Bernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Clinical and Translational Allergy
|
March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model
Bernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
Allergy
|
May 14, 2022
Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
Bernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Allergy
|
November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
Bernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
|
July 16, 2026
Baseline inflammatory markers, CPAP adherence, impacts on cardiovascular events, and mortality in obstructive sleep apnea: retrospective naturalistic study
Petr Mooz, Samuel Genzor, Jan Mizera, et al.
Viruses
|
November 11, 2022
Network Analysis for Uncovering the Relationship between Host Response and Clinical Factors to Virus Pathogen: Lessons from SARS-CoV-2
Milan Sova, Milos Kudelka, Milan Raska, et al.
British Journal of Anaesthesia
|
May 15, 2025
Multimodal prehabilitation before lung resection surgery: a multicentre randomised controlled trial
Kristian Brat, Milan Sova, Pavel Homolka, et al.
Cell Reports
|
June 20, 2025
The SARS-CoV-2 trigger highlights host interleukin 1 genetics in Epstein-Barr virus reactivation
Petra Schneiderova, Jan Mizera, Arootin Gharibian, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
February 16, 2025
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study
Bernardo Sousa-Pinto, Elísio M Costa, Rafael José Vieira, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 25, 2022
Cutoff Values of MASK-air Patient-Reported Outcome Measures
Bernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Allergy
|
March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world data
Bernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Clinical and Translational Allergy
|
March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model
Bernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
Allergy
|
May 14, 2022
Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
Bernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Allergy
|
November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
Bernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Page
of 6